Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-21-011803
Filing Date
2021-04-06
Accepted
2021-04-06 16:08:08
Documents
3
Effectiveness Date
2021-04-06

Document Format Files

Seq Description Document Type Size
1 FORM S-8 nt10015006x19_s8.htm S-8 60964
2 EXHIBIT 5.1 nt10015006x19_ex5-1.htm EX-5.1 20299
3 EXHIBIT 23.1 nt10015006x19_ex23-1.htm EX-23.1 1972
  Complete submission text file 0001140361-21-011803.txt   84243
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-255061 | Film No.: 21809285
SIC: 2834 Pharmaceutical Preparations